Korean-American Professional Association in Life Sciences (KAPAL) is a non-profit organization open to anyone who is interested in learning life science, sharing knowledge, and contributing to the development of all areas of life science.
Main themes are artificial intelligence & machine learning in bioscience
, and FDA regulatory perspective on cell therapy. Dr. James JungKue Lee (CEO, Bridge Biotherapeutics) will address the keynote.
Last year KAPAL had over 250 registrees and 51 companies participated in the conference.
For more information and updates visit KAPAL.ORG